Theronomic Flora Reshape - Akkermansia

Product Overview

Akkermansia muciniphila is a gram-negative anaerobic bacterium that naturally inhabits the intestinal mucus layer and constitutes approximately 1–3% of the healthy gut microbiome. It plays a central role in maintaining mucosal barrier integrity by stimulating goblet cell mucin production, downregulating inflammatory cytokines including TNF-α and IL-6, and signalling through short-chain fatty acid (SCFA) pathways. Reduced Akkermansia abundance — observed in obesity, type 2 diabetes, inflammatory bowel conditions, and metabolic syndrome — is increasingly recognised as a therapeutic target in metabolic medicine. Theronomic's Flora Reshape formulation uses pasteurised (not live) Akkermansia muciniphila MucT™, a form demonstrated in a landmark 2019 Nature Medicine trial (Depommier et al.) to retain full efficacy for glycaemic, lipid, and insulin sensitivity endpoints, with a superior safety profile compared to live bacterial preparations.

The tribiotic formulation distinguishes itself from standard probiotic supplements by combining prebiotic substrates specifically selected to support Akkermansia establishment: Livaux® (Actazin gold kiwi extract) increases Faecalibacterium prausnitzii and lowers the Firmicutes:Bacteroidetes ratio; Solnul™ potato resistant starch provides a highly selective fermentation substrate for colonocyte-supportive SCFA production. Together, these prebiotics create an intestinal microenvironment conducive to durable Akkermansia colonisation rather than transient supplementation. The companion Lactobacillus and Bifidobacterium strains provide additional competitive exclusion of pathobionts and support immunomodulatory Treg cell differentiation in the intestinal lamina propria.

Specifications

Key Applications and Indications

• Metabolic health and weight management: Restoration of Akkermansia abundance in individuals with metabolic syndrome, central obesity, or elevated fasting blood glucose; supported by the Depommier et al. Nature Medicine RCT demonstrating improvements in insulin sensitivity, plasma lipids, and body composition
• Intestinal permeability ("leaky gut"): Akkermansia muciniphila directly stimulates mucin (MUC2) production and tightens epithelial junctions, reducing endotoxaemia from lipopolysaccharide (LPS) translocation — a mechanism implicated in systemic low-grade inflammation
• Post-antibiotic gut microbiome restoration: Antibiotics significantly deplete Akkermansia colonisation; tribiotic supplementation with prebiotic support facilitates faster microbiome restitution after antibiotic courses
• Inflammatory bowel condition management support: Adjunctive use alongside dietary and medical management for individuals with dysbiosis-associated gastrointestinal symptoms; Akkermansia's anti-inflammatory signalling supports mucosal immune homeostasis
• Ageing and longevity medicine: Akkermansia abundance decreases with age; supplementation is used in longevity medicine protocols alongside NAD+ precursors and senolytics to support metabolic resilience in the ageing gut microbiome

Frequently Asked Questions

Q: Why is Theronomic Flora Reshape formulated with pasteurised rather than live Akkermansia muciniphila?
A: Akkermansia muciniphila is an obligate anaerobe that is rapidly inactivated by oxygen and stomach acid, making viable oral delivery of live bacteria technically challenging. The 2019 Nature Medicine randomised controlled trial by Depommier et al. demonstrated that pasteurised (heat-killed) Akkermansia muciniphila MucT™ was equally or more effective than live preparations for metabolic parameters including insulin sensitivity, plasma lipids, and gut permeability markers — while also demonstrating a safer adverse event profile. Pasteurised formulations also provide superior shelf stability without refrigeration requirements during transport.

Q: How long does it take to notice improvements from Akkermansia supplementation?
A: Clinical evidence suggests measurable changes in metabolic markers (fasting insulin, HOMA-IR, plasma lipids) become statistically significant at 12 weeks in research settings. Subjective improvements in digestive comfort and bloating may be noticed earlier (2–4 weeks) as the prebiotic components support microbiome rebalancing. Individual response depends on baseline Akkermansia abundance, dietary fibre intake, and concurrent antibiotic or medication use.

Q: Is Flora Reshape – Akkermansia suitable for use in Singapore? Is it HSA-approved?
A: Flora Reshape – Akkermansia is TGA-registered in Australia (ARTG 491665), confirming its safety and quality as a listed complementary medicine under the Australian Therapeutic Goods Act 1989. In Singapore, this product is classified as a health supplement under HSA's Health Products Act. It does not require individual HSA product registration as a health supplement but must comply with HSA's compositional guidelines for probiotics and prebiotics. Consumers are advised to consult a healthcare professional before commencing supplementation.

Q: Can this supplement be taken alongside prescription medications?
A: Individuals taking immunosuppressant medications, undergoing chemotherapy, or with severe immunodeficiency should consult their treating physician before commencing any probiotic or prebiotic supplementation. For healthy adults and those with metabolic conditions, probiotic supplements at the concentrations in Flora Reshape are generally considered low-risk when taken as directed. Concurrent use with antibiotics should be timed with a 2-hour separation to preserve probiotic viability.

Q: Where can Singapore healthcare professionals or clinics order Flora Reshape – Akkermansia in bulk?
A: EMIS Asia supplies Theronomic Flora Reshape – Akkermansia to Singapore longevity clinics, functional medicine practitioners, integrative health centres, and corporate wellness programmes on a B2B basis. Contact EMIS Asia for clinic pricing, minimum order quantities, and patient prescription pad support materials.